Press "Enter" to skip to content

New patent expiration for APIL drug MINASTRIN 24 FE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug MINASTRIN 24 FE

Annual Drug Patent Expirations for MINASTRIN+24+FE
Annual Drug Patent Expirations for MINASTRIN+24+FE

Minastrin 24 Fe is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

Drug patent litigation for MINASTRIN 24 FE.

The generic ingredient in MINASTRIN 24 FE is ethinyl estradiol; norethindrone acetate. Two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for APIL drug MINASTRIN 24 FE
Do NOT follow this link or you will be banned from the site!